Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Generic Sweden ABOSTO:GENI -2.10%91 EBITDA Margin % is 20.82% as of Mar. 2026, which is 7% above its 10-year median of 19.45. GuruFocus rates OSTO:GENI with a GF Score™ of 91/100 and a GF Value™ of kr59.49 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 2,820 Software companies, Generic Sweden AB ranks better than 79.68% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Generic Sweden AB's EBITDA for the
three
months ended in Mar. 2026 was kr10.2 Mil. Generic Sweden AB's Revenue for the
three
months ended in Mar. 2026 was kr48.9 Mil. Therefore, Generic Sweden AB's EBITDA margin for the quarter that ended in Mar. 2026 was 20.82%.
Generic Sweden AB (OSTO:GENI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Generic Sweden AB EBITDA Margin % Related Terms
Generic Sweden AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Generic Sweden AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:GENI vs UBER, SHOP, CRM: EBITDA Margin % Comparison
For the Software - Application subindustry, Generic Sweden AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Generic Sweden AB EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Generic Sweden AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Generic Sweden AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Generic Sweden AB (OSTO:GENI) has a EBITDA Margin % of 20.82% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Generic Sweden AB and its competitors. This is near median its historical median of 19.45. Over the past decade, Generic Sweden AB's EBITDA Margin % has ranged from 12.10 to 21.95. According to the industry distribution chart, Generic Sweden AB ranks #573 out of 2820 companies in the Software industry, placing it in the top 20.3%.
Is Generic Sweden AB's EBITDA Margin % too high?
Generic Sweden AB's current EBITDA Margin % of 20.82% is near median its 10-year median of 19.45. Over the past 10 years, this metric has ranged from a low of 12.10 to a high of 21.95. The Software industry median EBITDA Margin % is 8.09. Generic Sweden AB's value of 20.82% is 157.5% above this industry median. Based on the distribution chart, Generic Sweden AB ranks #573 out of 2820 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Generic Sweden AB has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Generic Sweden AB's EBITDA Margin % compare to UBER and SHOP?
According to the Software industry distribution chart, Generic Sweden AB ranks #573 out of 2820 companies for EBITDA Margin %. This places Generic Sweden AB in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.09. Generic Sweden AB's value of 20.82% is 157.5% above this benchmark. Historically, Generic Sweden AB's own EBITDA Margin % has ranged from 12.10 to 21.95 over the past decade. While the company's 10-year median is 19.45 vs. the industry median of 8.09, Generic Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.09, based on 2,820 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Generic Sweden AB's current EBITDA Margin % of 20.82% is 157.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Generic Sweden AB and its competitors. For the Software industry, the median EBITDA Margin % is 8.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Generic Sweden AB's current EBITDA Margin % is 20.82%, which is near median its own 10-year median of 19.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Generic Sweden AB (OSTO:GENI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr59.49, compared to a current price of kr37.30 — trading 37.3% below its estimated fair value. The current EBITDA Margin % is 20.82%, which is near median its 10-year median of 19.45 and 157.5% above the Software industry median of 8.09. Generic Sweden AB's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Generic Sweden AB (OSTO:GENI), the current EBITDA Margin % is 20.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Generic Sweden AB (OSTO:GENI) Overvalued in 2026?
Based on GuruFocus' analysis, Generic Sweden AB stock appears to be undervalued.
The current stock price of kr37.30 is trading 37.3% below its estimated GF Value™ of kr59.49.
GuruFocus considers Generic Sweden AB to be Significantly Undervalued.
Key valuation signals for OSTO:GENI:
EBITDA Margin %: 20.82% (near median its 10-year median of 19.45)
GF Value™: kr59.49 vs. price of kr37.30 (37.3% below fair value)
Industry Position: 157.5% above the Software median (#573 of 2820)
No single metric tells the full story. See the OSTO:GENI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Generic Sweden AB is a technology company providing high-tech messaging services for all applications. The company offers a platform for digital communication services that can be integrated into customers' internal or external communication flow. The services are provided through a Communication Platform as a Service (CPaaS) model. Generic's customers are found in all areas and with a special position in alarms and security, care and e-health as well as e-commerce and logistics.
91GF Score
Get the complete analysis for OSTO:GENI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:GENI has been successfully added to your 
